Patty Cruite
About Patty Cruite
Patty Cruite is a Senior Scientist at Sana Biotechnology, Inc., where she leads the discovery and characterization of compositions for CAR-T programs. With a strong background in biochemistry and extensive experience in vector targeting, she has contributed significantly to biologics and gene therapy research.
Work at Sana Biotechnology
Patty Cruite serves as a Senior Scientist at Sana Biotechnology, Inc. since 2019. In this role, she has led the discovery and characterization of a lead composition for the company's in vivo CAR-T program. She has also acted as the subject matter expert in binder discovery, contributing to the advancement of various discovery programs. Her work focuses on biologics and gene therapy, driving programs from conception to pre-IND studies.
Education and Expertise
Patty Cruite holds a Master of Science (MS) in Biochemistry from The University of Texas at Austin, where she studied from 2007 to 2010. Prior to that, she earned a Bachelor of Science (BSc) in Biochemistry from Case Western Reserve University, completing her studies from 2003 to 2007. Her academic background supports her extensive experience in vector targeting and specificity assays, as well as her management of discovery programs utilizing various binder formats such as scFvs, VHHs, and full IgGs.
Background
Before joining Sana Biotechnology, Patty Cruite worked as an Associate Scientist at Adimab, LLC from 2011 to 2019. During her eight years at Adimab, she gained valuable experience in biologics and gene therapy. Earlier in her career, she was a Graduate Student at the University of Texas at Austin from 2007 to 2010, where she focused on her studies in biochemistry.
Achievements
Patty Cruite has successfully driven programs in biologics and gene therapy from conception to pre-IND studies. Her leadership in the discovery and characterization of a lead composition for Sana's in vivo CAR-T program highlights her contributions to the field. Additionally, her role as a subject matter expert in binder discovery at Sana Biotechnology emphasizes her expertise and influence in the industry.